Variant report

Variant	nsv432432
Chromosome Location	chr3:75377715-75639894
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2817)
CpG islands
(count:2628)
Chromatin interactive
region (count:10)
LncRNA
region (count:23)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2817 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:75601426-75601483	K562	blood:	n/a	n/a
2	ARID3A	chr3:75482025-75482381	HepG2	liver:	n/a	n/a
3	ATF1	chr3:75482136-75482245	K562	blood:	n/a	n/a
4	ATF1	chr3:75484451-75484710	K562	blood:	n/a	n/a
5	ATF1	chr3:75442553-75442767	K562	blood:	n/a	n/a
6	ATF3	chr3:75482021-75482341	K562	blood:	n/a	n/a
7	ATF3	chr3:75482035-75482349	A549	lung:	n/a	n/a
8	BACH1	chr3:75390901-75391145	H1-hESC	embryonic stem cell:	n/a	n/a
9	BATF	chr3:75466555-75466915	GM12878	blood:	n/a	chr3:75466774-75466785
10	BATF	chr3:75466554-75466845	GM12878	blood:	n/a	chr3:75466774-75466785
11	BATF	chr3:75478786-75479063	GM12878	blood:	n/a	n/a
12	BATF	chr3:75544610-75544819	GM12878	blood:	n/a	chr3:75544723-75544731
13	BATF	chr3:75551282-75551694	GM12878	blood:	n/a	n/a
14	BATF	chr3:75468128-75468306	GM12878	blood:	n/a	n/a
15	BATF	chr3:75483970-75484356	GM12878	blood:	n/a	n/a
16	BATF	chr3:75596078-75596520	GM12878	blood:	n/a	n/a
17	BATF	chr3:75573564-75573871	GM12878	blood:	n/a	n/a
18	BATF	chr3:75411520-75411813	GM12878	blood:	n/a	n/a
19	BATF	chr3:75484448-75484647	GM12878	blood:	n/a	n/a
20	BATF	chr3:75483026-75483267	GM12878	blood:	n/a	n/a
21	BATF	chr3:75527612-75527941	GM12878	blood:	n/a	n/a
22	BATF	chr3:75467667-75467909	GM12878	blood:	n/a	n/a
23	BATF	chr3:75471237-75471503	GM12878	blood:	n/a	n/a
24	BATF	chr3:75483065-75483278	GM12878	blood:	n/a	n/a
25	BATF	chr3:75411604-75411874	GM12878	blood:	n/a	n/a
26	BATF	chr3:75551286-75551692	GM12878	blood:	n/a	n/a
27	BATF	chr3:75547955-75548333	GM12878	blood:	n/a	n/a
28	BATF	chr3:75548046-75548331	GM12878	blood:	n/a	n/a
29	BATF	chr3:75573541-75573863	GM12878	blood:	n/a	n/a
30	BATF	chr3:75551976-75552365	GM12878	blood:	n/a	n/a
31	BATF	chr3:75566162-75566431	GM12878	blood:	n/a	n/a
32	BATF	chr3:75386395-75386620	GM12878	blood:	n/a	n/a
33	BATF	chr3:75471192-75471564	GM12878	blood:	n/a	n/a
34	BATF	chr3:75483500-75483898	GM12878	blood:	n/a	chr3:75483518-75483528 chr3:75483514-75483524
35	BCL11A	chr3:75547956-75548367	GM12878	blood:	n/a	chr3:75548358-75548367
36	BCL11A	chr3:75615329-75615521	GM12878	blood:	n/a	n/a
37	BCL11A	chr3:75483449-75483810	GM12878	blood:	n/a	chr3:75483516-75483525
38	BCL11A	chr3:75573652-75573882	GM12878	blood:	n/a	chr3:75573771-75573780
39	BCL11A	chr3:75483447-75484322	GM12878	blood:	n/a	chr3:75483516-75483525
40	BCL11A	chr3:75484021-75484296	GM12878	blood:	n/a	n/a
41	BCL11A	chr3:75527598-75527864	GM12878	blood:	n/a	n/a
42	BCL11A	chr3:75547962-75548278	GM12878	blood:	n/a	n/a
43	BCL11A	chr3:75471159-75471563	GM12878	blood:	n/a	n/a
44	BCL11A	chr3:75544573-75544904	GM12878	blood:	n/a	chr3:75544808-75544817
45	BCL11A	chr3:75551326-75551720	GM12878	blood:	n/a	n/a
46	BCL11A	chr3:75482472-75482657	GM12878	blood:	n/a	n/a
47	BCL11A	chr3:75483008-75483267	GM12878	blood:	n/a	n/a
48	BCL11A	chr3:75551437-75551623	GM12878	blood:	n/a	n/a
49	BCL11A	chr3:75609659-75609871	GM12878	blood:	n/a	n/a
50	BCL11A	chr3:75471268-75471550	GM12878	blood:	n/a	n/a

(count:2628 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:75415561-75415611	AG04450	lung:	fetal
2	chr3:75414693-75414743	AG04449	skin:	fetal
3	chr3:75441804-75441854	HRPEpiC	eye:	n/a
4	chr3:75441804-75441854	Hepatocyte	liver:	n/a
5	chr3:75445738-75445788	NB4	blood:	n/a
6	chr3:75415561-75415611	AG04450	lung:	fetal
7	chr3:75414693-75414743	AG04449	skin:	fetal
8	chr3:75441804-75441854	HRPEpiC	eye:	n/a
9	chr3:75441804-75441854	Hepatocyte	liver:	n/a
10	chr3:75445738-75445788	NB4	blood:	n/a
11	chr3:75555938-75555988	AG04449	skin:	fetal
12	chr3:75412866-75412916	HPAEpiC	pulmonary alveolar:	n/a
13	chr3:75628932-75628982	HRE	kidney:	n/a
14	chr3:75414693-75414743	K562	blood:	n/a
15	chr3:75629039-75629089	PrEC	prostate:	n/a
16	chr3:75485448-75485498	HEEpiC	esophagus:	n/a
17	chr3:75553762-75553812	SKMC	muscle:	n/a
18	chr3:75441804-75441854	NHDF-neo	bronchial:	n/a
19	chr3:75632533-75632583	HCT-116	colon:	n/a
20	chr3:75482182-75482232	HepG2	liver:	n/a
21	chr3:75448983-75449033	NHBE	bronchial:	n/a
22	chr3:75412866-75412916	T-47D	breast:	n/a
23	chr3:75445095-75445145	LNCaP	prostate:	n/a
24	chr3:75632533-75632583	IMR90	lung:	fetal
25	chr3:75553723-75553773	RPTEC	kidney:	n/a
26	chr3:75629433-75629483	HCPEpiC	choroid plexus:	n/a
27	chr3:75415561-75415611	SK-N-MC	brain:	n/a
28	chr3:75445738-75445788	HepG2	liver:	n/a
29	chr3:75484440-75484490	AG09309	skin:	n/a
30	chr3:75443047-75443097	GM06990	blood:	n/a
31	chr3:75411217-75411267	Caco-2	colon:	n/a
32	chr3:75556027-75556077	ovcar-3	ovarian:	n/a
33	chr3:75415526-75415576	AG09309	skin:	n/a
34	chr3:75445502-75445552	K562	blood:	n/a
35	chr3:75410747-75410797	K562	blood:	n/a
36	chr3:75628819-75628869	HL-60	blood:	n/a
37	chr3:75444752-75444802	T-47D	breast:	n/a
38	chr3:75416171-75416221	GM12891	blood:	n/a
39	chr3:75482182-75482232	NHBE	bronchial:	n/a
40	chr3:75415526-75415576	AG09319	gingival:	n/a
41	chr3:75483803-75483853	HRCEpiC	kidney:	n/a
42	chr3:75412866-75412916	HEK293	kidney:	embryo
43	chr3:75415526-75415576	T-47D	breast:	n/a
44	chr3:75410747-75410797	A549	lung:	n/a
45	chr3:75444752-75444802	PFSK-1	brain:	n/a
46	chr3:75632533-75632583	HIPEpiC	eye:	n/a
47	chr3:75628819-75628869	AG09309	skin:	n/a
48	chr3:75411038-75411088	GM06990	blood:	n/a
49	chr3:75414486-75414536	HCM	heart:	n/a
50	chr3:75445502-75445552	AoSMC	blood vessel:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:75390707..75391392-chr3:75471007..75471537,3	MCF-7	breast:
2	chr3:75390707..75391392-chr3:75471007..75471537,3	MCF-7	breast:
3	chr11:71498107..71498639-chr3:75483883..75484386,2	Hela-S3	cervix:
4	chr3:75343035..75343810-chr3:75470999..75471871,7	MCF-7	breast:
5	chr3:75466672..75467412-chr3:129812592..129813394,2	NB4	blood:
6	chr3:75343239..75343917-chr3:75478470..75479360,2	MCF-7	breast:
7	chr3:75343397..75343923-chr3:75600934..75601577,2	MCF-7	breast:
8	chr3:75484863..75485638-chr6:26156199..26156944,2	HCT-116	colon:
9	chr3:75343455..75344253-chr3:75389889..75390567,2	MCF-7	breast:
10	chr3:75343052..75344300-chr3:75470848..75471840,6	MCF-7	breast:

(count:23 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FRG2C-2	chr3:75606223-75606260	XLOC_002712
2	lnc-FRG2C-3	chr3:75497520-75500553	NONHSAT090533
3	lnc-FRG2C-3	chr3:75485367-75485503	XLOC_002710
4	lnc-FRG2C-3	chr3:75492659-75492775	XLOC_002710
5	lnc-ZNF717-3	chr3:75589200-75589378	ENSG00000272710.1
6	lnc-FRG2C-3	chr3:75501683-75501794	NONHSAT090533
7	lnc-FRG2C-3	chr3:75484499-75484564	ENSG00000272690.1
8	lnc-FRG2C-3	chr3:75501348-75501809	ENSG00000272690.1
9	lnc-FRG2C-2	chr3:75606117-75606146	XLOC_002712
10	lnc-FRG2C-11	chr3:75570954-75571163	NONHSAT090534
11	lnc-FRG2C-3	chr3:75505768-75506637	ENSG00000272690.1
12	lnc-FRG2C-3	chr3:75501683-75501802	ENSG00000272690.1
13	lnc-FRG2C-3	chr3:75500361-75500553	ENSG00000272690.1
14	lnc-FRG2C-3	chr3:75492659-75492797	ENSG00000272690.1
15	lnc-FRG2C-2	chr3:75608026-75608398	XLOC_002712
16	lnc-FRG2C-3	chr3:75485928-75486426	XLOC_002710
17	lnc-FRG2C-2	chr3:75608026-75608433	XLOC_002712
18	lnc-FRG2C-3	chr3:75488905-75488997	XLOC_002710
19	lnc-FRG2C-3	chr3:75486207-75486426	XLOC_002710
20	lnc-FRG2C-3	chr3:75500361-75500553	ENSG00000272690.1
21	lnc-FRG2C-3	chr3:75496316-75496447	ENSG00000272690.1
22	lnc-ZNF717-3	chr3:75629129-75629150	ENSG00000272710.1
23	lnc-FRG2C-3	chr3:75488905-75488988	XLOC_002710

No data

Variant related genes	Relation type
ENSG00000239383	TF binding region
FAM86DP	TF binding region
ENSG00000266685	TF binding region
ENSG00000242953	TF binding region
OR7E55P	TF binding region
ENSG00000221602	TF binding region
OR7E66P	TF binding region
MYLKP1	TF binding region
RPS3AP15	TF binding region
ENSG00000243794	TF binding region
OR7E22P	TF binding region
LSP1P2	TF binding region
ENSG00000263782	TF binding region
ENPP7P2	TF binding region
ALG1L6P	TF binding region
ENSG00000272690	TF binding region
ENSG00000244699	TF binding region
ENSG00000272710	TF binding region
ENSG00000239383	CpG island
FAM86DP	CpG island
ENSG00000266685	CpG island
ENSG00000242953	CpG island
OR7E55P	CpG island
ENSG00000221602	CpG island
OR7E66P	CpG island
MYLKP1	CpG island
RPS3AP15	CpG island
ENSG00000243794	CpG island
OR7E22P	CpG island
LSP1P2	CpG island
ENSG00000263782	CpG island
ENPP7P2	CpG island
ALG1L6P	CpG island
ENSG00000272690	CpG island
ENSG00000244699	CpG island
ENSG00000272710	CpG island
ENSG00000168298	chromatin interactions
ENSG00000248243	chromatin interactions
ENSG00000251287	chromatin interactions
ENSG00000158483	chromatin interactions
ITGB1	miRNA target sites
SFRS5	miRNA target sites

Extended variants
information (count: 10742 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:10742 , 50 per page) page: 1 2 3 4 5 6 7 ... 215

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4677496	chr3:75377715-75377716	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs567387125	chr3:75377729-75377730	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs374487444	chr3:75377770-75377771	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs577355254	chr3:75377771-75377772	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs537557071	chr3:75377773-75377774	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs555811702	chr3:75377776-75377777	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs375059645	chr3:75377780-75377781	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs570912784	chr3:75377823-75377824	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs538205970	chr3:75377849-75377850	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs553689895	chr3:75377875-75377876	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs112487847	chr3:75377908-75377909	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs542842492	chr3:75377909-75377910	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs78268217	chr3:75377911-75377912	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs114235312	chr3:75377941-75377942	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs192867384	chr3:75377946-75377947	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs562932769	chr3:75377958-75377959	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs534932481	chr3:75377998-75377999	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs545418980	chr3:75378006-75378007	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs560867169	chr3:75378008-75378009	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs527961915	chr3:75378075-75378076	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs117435260	chr3:75378101-75378102	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs4677497	chr3:75378125-75378126	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs143420376	chr3:75378146-75378147	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs549474999	chr3:75378156-75378157	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs368529855	chr3:75378192-75378193	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs371984143	chr3:75378226-75378227	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs553337675	chr3:75378227-75378228	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs565637910	chr3:75378262-75378263	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs565788953	chr3:75378265-75378266	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs185836257	chr3:75378286-75378287	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs576169472	chr3:75378304-75378305	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs543635289	chr3:75378316-75378317	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs55753705	chr3:75378319-75378320	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs578126440	chr3:75378320-75378321	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs189156131	chr3:75378325-75378326	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs560299059	chr3:75378348-75378349	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs17028093	chr3:75378353-75378354	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs544130803	chr3:75378424-75378425	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs180884532	chr3:75378429-75378430	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs561587354	chr3:75378433-75378434	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs75270902	chr3:75378434-75378435	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs549958238	chr3:75378444-75378445	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs571045849	chr3:75378448-75378449	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs184950648	chr3:75378471-75378472	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs547441135	chr3:75378481-75378482	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs542825248	chr3:75378482-75378483	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs559552078	chr3:75378485-75378486	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs78033678	chr3:75378499-75378500	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs112506856	chr3:75378502-75378503	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs537273065	chr3:75378504-75378505	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Acute myeloid leukemia	20729466	CNVD
Glioblastoma multiforme	21080181	CNVD
Melanoma	18172304	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	21251322	CNVD
Hirschsprung''s Disease	21712996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Autism	22102821	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Prostate cancer	18632612	CNVD
Metanephric adenoma	20802469	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21509527	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Colorectal cancer	16272173	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Soft tissue tumor	16732325	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Williams Syndrome	20824207	CNVD
Melanoma	20877625	CNVD
Ollier disease	21235737	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD

Chromatin state (count:1743 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:75375000-75382400	Weak transcription	Gastric	stomach
2	chr3:75376000-75382800	Enhancers	Breast Myoepithelial Primary Cells	Breast
3	chr3:75376200-75378200	Active TSS	Pancreas	Pancrea
4	chr3:75376600-75379400	Enhancers	Fetal Lung	lung
5	chr3:75376800-75381600	Weak transcription	Right Atrium	heart
6	chr3:75377200-75377800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr3:75377400-75377800	Enhancers	Spleen	Spleen
8	chr3:75377400-75378600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr3:75377600-75377800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
10	chr3:75377600-75378000	Active TSS	Stomach Smooth Muscle	stomach
11	chr3:75377600-75378800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr3:75377800-75380400	Weak transcription	Spleen	Spleen
13	chr3:75378200-75378400	Bivalent Enhancer	Fetal Stomach	stomach
14	chr3:75378200-75378600	Flanking Active TSS	Pancreas	Pancrea
15	chr3:75378200-75379400	Enhancers	Cortex derived primary cultured neurospheres	brain
16	chr3:75378400-75378600	Bivalent Enhancer	Fetal Muscle Leg	muscle
17	chr3:75378400-75378600	Flanking Active TSS	Fetal Stomach	stomach
18	chr3:75378400-75379200	Enhancers	Stomach Smooth Muscle	stomach
19	chr3:75378600-75378800	Active TSS	Pancreas	Pancrea
20	chr3:75378600-75379200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr3:75378600-75379400	Enhancers	Fetal Stomach	stomach
22	chr3:75378600-75379800	Enhancers	Fetal Muscle Trunk	muscle
23	chr3:75378600-75380000	Enhancers	Fetal Muscle Leg	muscle
24	chr3:75378800-75379800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr3:75378800-75380400	Weak transcription	Pancreas	Pancrea
26	chr3:75379000-75379200	Enhancers	Colon Smooth Muscle	Colon
27	chr3:75379000-75379400	Enhancers	Brain Germinal Matrix	brain
28	chr3:75379200-75380600	Weak transcription	Colon Smooth Muscle	Colon
29	chr3:75379200-75380600	Weak transcription	Stomach Smooth Muscle	stomach
30	chr3:75379400-75381400	Weak transcription	Fetal Lung	lung
31	chr3:75379800-75381200	Weak transcription	Fetal Muscle Trunk	muscle
32	chr3:75380000-75381400	Weak transcription	Fetal Muscle Leg	muscle
33	chr3:75380400-75380800	Enhancers	HepG2	liver
34	chr3:75380400-75381000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
35	chr3:75380400-75381000	Enhancers	Pancreas	Pancrea
36	chr3:75380400-75382600	Enhancers	Spleen	Spleen
37	chr3:75380600-75381400	Enhancers	Stomach Smooth Muscle	stomach
38	chr3:75380600-75382800	Enhancers	Colon Smooth Muscle	Colon
39	chr3:75380800-75381800	Enhancers	Duodenum Smooth Muscle	Duodenum
40	chr3:75381000-75382400	Weak transcription	Pancreas	Pancrea
41	chr3:75381000-75382600	Enhancers	Fetal Stomach	stomach
42	chr3:75381000-75382600	Enhancers	NHLF	lung
43	chr3:75381200-75383200	Enhancers	Fetal Muscle Trunk	muscle
44	chr3:75381200-75383600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr3:75381400-75381800	Flanking Active TSS	Stomach Smooth Muscle	stomach
46	chr3:75381400-75382600	Enhancers	Fetal Lung	lung
47	chr3:75381400-75382800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr3:75381400-75382800	Enhancers	Fetal Muscle Leg	muscle
49	chr3:75381600-75381800	Enhancers	Right Atrium	heart
50	chr3:75381600-75382000	Enhancers	Small Intestine	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links